Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.

We report the effectiveness and adverse effects of triple therapy with hydroxychloroquine, azithromycin, and ciclesonide in patients with COVID-19 pneumonia. The clinical condition of the patients improved within 5 days in response to the therapy. PMID: 33054978 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33054978?dopt=Abstract

Source: Journal of Microbiology, Immunology, and Infection - October 5, 2020 Category: Microbiology Authors: Mori N, Katayama M, Nukaga S Tags: J Microbiol Immunol Infect Source Type: research